tiprankstipranks
DermTech Inc (DMTK)
NASDAQ:DMTK
US Market

DermTech (DMTK) Income Statement

718 Followers

DermTech Income Statement

Last quarter (Q3 2023), DermTech's total revenue was $3.92M, an increase of 9.57% from the same quarter last year. In Q3, DermTech's net income was $-19.16M. See DermTech’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 22Dec 21Dec 20Dec 19Mar 19
Total Revenue
$ 14.37M$ 14.52M$ 11.84M$ 5.88M$ 3.36M$ 0.00
Cost of Revenue
$ 7.25M$ -13.87M$ 10.56M$ 5.98M$ 3.30M-
Gross Profit
$ 642.00K$ 647.00K$ -10.56M$ -96.00K$ 60.00K-
Operating Expense
$ 116.32M$ -118.81M$ 78.67M$ 35.19M$ 17.66M$ 1.98M
Operating Income
$ -119.34M$ -132.68M$ -89.24M$ -35.29M$ -17.61M$ -1.98M
Net Non Operating Interest Income Expense
$ 2.83M$ 1.34M$ 151.00K$ 40.00K$ -2.66M$ 2.86M
Other Income Expense
$ -6.49M$ -14.66M$ -10.75M$ -1.23M$ 573.00K$ 59.36K
Pretax Income
$ -110.02M$ -116.68M$ -78.33M$ -36.48M$ -19.69M$ 944.46K
Tax Provision
------
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -110.02M$ -116.68M$ -78.33M$ -36.48M$ -19.69M$ 743.39K
Basic EPS
$ -4.51$ -3.88$ -2.71$ -2.08$ -2.81$ 0.28
Diluted EPS
$ -3.50$ -3.88$ -2.71$ -2.08$ -2.81$ 0.28
Basic Average Shares
$ 126.22M$ 30.04M$ 28.88M$ 16.98M$ 7.01M$ 2.57M
Diluted Average Shares
$ 126.22M$ 30.04M$ 28.88M$ 16.98M$ 7.01M$ 2.57M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 123.57M$ -132.68M$ 89.24M$ 41.17M$ 20.97M$ 1.98M
Net Income From Continuing And Discontinued Operation
$ -110.02M$ -116.68M$ -78.33M$ -36.48M$ -19.69M$ 944.46K
Normalized Income
$ -36.17M--$ -35.25M$ -20.62M$ 901.12K
Interest Expense
----$ 2.66M-
EBIT
$ -110.66M$ -116.70M$ -78.35M$ -35.29M$ -17.61M$ -1.98M
EBITDA
$ -106.61M$ -111.83M$ -75.31M$ -34.80M$ -17.52M$ -1.98M
Currency in USD

DermTech Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis